Table 3.
Secondary analyses of primary and secondary outcomes: change in depression (PHQ-9) and anxiety (GAD-7) from baseline to 8 weeks (n = 47).
| PHQ-9 |
Treatment (BMI)
(n = 21) |
Active Control (HEP)
(n = 26) |
| Baseline | 9.3 (±3.2) | 10.0 (±4.8) |
| Follow-up | 5.2 (±3.3) | 6.9 (±4.1) |
| 8-week Change | −5 pts (−7–−1) | −3 pts (−5–0) |
| Between-group Change |
p = 0.23 95% CI = [−4, 1] |
|
| GAD-7 |
Treatment (BMI)
(n = 21) |
Active Control (HEP)
(n = 26) |
| Baseline | 7.0 (±5.4) | 6.8 (±3.8) |
| Follow-up | 3.9 (±4.0) | 5.8 (±4.8) |
| 8-week Change | −3.1 pts (±4.7) | −1 pts (±3.9) |
| Between-group Change |
p = 0.1 95% CI = [−4.61, 0.4] |
|